Magnetic Resonance Imaging (MRI) in Patients With Pacemakers and Implanted Cardioverter Defibrillators
Launched by JOHNS HOPKINS UNIVERSITY · Sep 2, 2016
Trial Information
Current as of July 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Pilot studies of approximately 1500 patients, RPN #03-08-12-11 and 00051707 (manuscript submitted) demonstrated the safety of most contemporary implanted rhythm management devices in the MRI environment given appropriate precautions.
When pilot studies were developed, there was a theoretical concern that there may be an increased risk associated with some device and device circumstances including: 1) PPM's or leads implanted prior to 1996; 2) ICD's implanted prior to 2000; 3) abandoned or endocardial leads; 4) leads implanted \<6 weeks; 5) ICD's where patient is pacemaker dependent.
While...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients implanted an ICD or pacemaker who have a clinical need for MR imaging
- Exclusion Criteria:
- • Patients who complete the MRI standard screening form and are deemed inappropriate for MRI for any reason
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Henry R Halperin, MD/MA
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials